* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download gastrointestinal drugs
Polysubstance dependence wikipedia , lookup
Toxicodynamics wikipedia , lookup
Orphan drug wikipedia , lookup
NMDA receptor wikipedia , lookup
Discovery and development of antiandrogens wikipedia , lookup
Discovery and development of beta-blockers wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Pharmacognosy wikipedia , lookup
Prescription costs wikipedia , lookup
Cannabinoid receptor antagonist wikipedia , lookup
5-HT3 antagonist wikipedia , lookup
Drug interaction wikipedia , lookup
Discovery and development of angiotensin receptor blockers wikipedia , lookup
NK1 receptor antagonist wikipedia , lookup
Neuropharmacology wikipedia , lookup
Psychopharmacology wikipedia , lookup
Discovery and development of proton pump inhibitors wikipedia , lookup
Gastrointestinal drugs 张世红 [email protected] Digestive diseases 1.Hepatic, pancreatic and biliary disorders 2.Acid-peptic disorders 3.Gastrointesinal motility disorders 4.Inflammatory bowel diseases (痔疮) (便秘) (消化不良) (胆石症) (疝气) (肠易激 综合征) (胃炎) (消化性溃疡) Gastrointestinal drugs 1. Drugs used for acid-peptic disorders 2. Modulators of gastrointestinal functions 1. Acid-peptic disorders 1) Peptic ulcer disease (PUD) 2) Gastroesophageal reflux disease (GERD) 3) Pathologic acid-hypersecretory conditions (e.g. Zollinger-Ellison syndrome) 4) Drug-induced mucosal injury, especially by non-steroidal anti-inflammatory drugs (NSAIDs) 5) Acute stress ulcers Peptic ulcer disease Symptoms: Upper abdominal burning or hunger pain Emesia (呕吐), belching (嗳气) Ulcer complication Ulcer bleeding (出血) Ulcer perforation (穿孔) Pyloristenosis (幽门狭窄) Canceration (癌变) Mucosa Submucosa Muscle Gastroesophageal reflux disease (GERD) Pathologic acid-hypersecretory conditions (e.g. Zollinger-Ellison syndrome) Tumor Gastrin Gastric acid Peptic ulcer 2. Pathogenesis of peptic ulcers Defensive factors Aggressive factors Mucus Gastric acid Pepsin (胃蛋白酶) Helicobacter pylori (幽门螺旋杆菌) Bicarbonate Mucosa Mucus-bicarbonate barrier Gastric acid secretion and regulation (the proton pump) Helicobacter pylori infection Marshall BJ Warren JR The Nobel prize in 2005: for their discovery of the bacterium Helicobacter pylori and its role in gastritis and peptic ulcer disease Pathogenesis of peptic ulcers Treatment approaches (1) Increased gastric acid secretion (1) Reducing secretion of gastric acid or neutralizing the acid (2) Infection with Helicobacter pylori (2) Eradicating根除 H. pylori infection (3) Inadequate mucosal defense against gastric acid (3) Protecting the gastric mucosa from damage 4. Drugs used for peptic ulcers (1) Antacids: neutralize中和 the acid (2) Drugs suppressing gastric acid secretion ① H2 receptor antagonists ② H+-K+-ATPase inhibitors (proton pump inhibitors) ③ Muscarinic receptor antagonists ④ Gastrin receptor antagonists (3) Mucosal protective drugs (4) Antimicrobial drugs (Helicobacter pylori) Antacids (weak bases) Chemistry of antacids: Aluminum salts (aluminum hydroxide) Magnesium salts (carbonate, hydroxide or oxide) Calcium salts (carbonate) Sodium salts (bicarbonate) Antacids (weak bases) 1. Pharmacological effects - Neutralize gastric acid, diminishing gastric acidity and inactivating pepsin(胃蛋白酶) - Form a protective membrane on the gastric mucosa - Depend on the dose and dosing frequency. - Effect starting within 5-15 min, lasting 1-3 h. 2. Clinical uses Commonly used for minor episodes of heartburn. Antacids (weak bases) 3. Adverse effects (1) Constipation and stomach cramp (Al/Ca salts ) (2) Diarrhea (Mg salts) (3) Hypercalcium (calcium salts) (4) Hypernatremia (sodium salts) 4. Drug interactions Affect rates of dissolution and absorption, bioavailability, and renal elimination of many drugs NOTICE (1) Take antacids 1 hour after meals Four times a day after meals and at bedtime. (2) Should not be taken continuously for more than 2 weeks (3) To help avoid or reduce drug interaction, other medication should be taken 1-2 hours after taking an antacid Drugs suppressing gastric acid secretion M receptor antagonists × Proton pump inhibitors H2 receptor antagonists × × Gastrin receptor antagonists × × Antacids H2 receptor antagonists Cimetidine 西咪替丁,甲腈咪胍 H3C CH2SCH2CH2NHCNHCH3 HN N N CN Cimetidine 1. Pharmacological effect Blocks H2 receptors, decreases H+ and pepsin secretion, promots ulcer healing. 2. Clinical uses 1) Duodenal and gastric ulcer (high rate of relapse) 2) Zollinger-Ellison syndrome 3) Acute stress ulcers 4) Gastroesophageal reflux disease (heartburn) 5) Decreased immune function Cimetidine 3. Adverse effects (1) common side effects: constipation, diarrhea, tiredness, muscular pain, etc. (2) CNS effects: headache, dizziness, confusion, hallucination, etc. (elderly, long-term uses) (3) Antiandrogen(抗雄激素)effects 4. Drug interactions Inhibits hepatic P450, raises plasma concentrations of warfarin, phenytoin, diazepam, propranolol, quinidine and theophylline, etc. Other H2 receptor antagonists Ranitidine (雷尼替丁) 4~10 times more potent than cimetidine; Minimal side effects, weakly inhibits CYP Famotidine (法莫替丁) 40-50 times more potent than cimetidine; no inhibition of CYP Nizatidine (尼扎替丁) High bioavailability (near 100%) H+-K+-ATPase inhibitors Omeprazole 奥美拉唑,洛赛克 OCH3 H3C CH3 N CH2 O OCH3 N S N H Omeprazole 1. Pharmacological effects (1) Inhibits gastric acid secretion induced by various stimuli (histamine, gastrin, aspirin, ethanol, stress) (2) Inhibits H. pylori 2. Clinical uses (1) Highly effective for duodenal and gastric ulcer, reflux esophagitis: relieves symptoms, promots healing of ulcers (2) Used with antimicrobial regimens to eradicate H. pylori Omeprazole 3. Adverse effects (1) Side effects: nausea, headache, diarrhea, constipation and rash (rare) (2) Increase of gastric carcinoid tumor: prolongated hypochlorhydria 胃酸过少症and secondary hypergastrinemia 高胃泌素症(only found in animal experiments) (3) Others: gynecomastia (男性乳房发育), hypersensitivity 4. Drug interactions Inhibits hepatic P450, raises plasma concentrations of warfarin, phenytoin, diazepam, etc. Others proton pump inhibitors M receptor antagonists Pirenzepine 哌仑西平 Mucosal protective drugs Effects: Protect the gastric and duodenal mucosa from damage by acid and pepsin Misoprostol 米索前列醇 Sucralfate 硫糖铝 Colloidal bismuth subcitrate 胶体次枸 橼酸铋 Mucosal protective drugs Misoprostol 米索前列醇 O O CH3 OCH3 OH HO A prostaglandin E analogues Misoprostol 米索前列醇 1. Pharmacological effects Inhibits gastric acid secretion Promots mucus and HCO3- secretion, mucosal repair 2. Clinical uses Approved for the prevention of NSAIDs-induced gastric ulcer. 3. Adverse effects Side effects (13%): abdominal pain, diarrhea, headache, nausea, etc. Contraindicated in pregnancy women: Abortifacient (堕胎) effect Mucosal protective drugs Sucralfate (硫糖铝) A sulfated disaccharide(硫酸蔗糖) complex of aluminum hydroxide Sucralfate 1. Pharmacological effects 1) Binds to tissue proteins and forms a protective barrier 2) Enhances cell restitution修复 and re-epithelization重上皮化 3) Weakly inhibits H.Pylory growth. 2. Clinical uses and adminstration Peptic ulcers Take sucralfate 1 hour before meals Four times a day before meals and at bedtime 3. Adverse effects Constipation occurs in 2% due to the aluminum salt Mucosal protective drugs Bismuth Compounds 铋制剂 Colloidal bismuth subcitrate (CBS, 胶体次枸橼酸铋) Bismuth subsalicylate次水杨酸铋 1. Pharmacological effects 1) Probably coats ulcers and erosions, creating a protective layer against acid and pepsin 2) Stimulates prostaglandin, mucus, and bicarbonate secretion 3) Kills H. pylori Bismuth Compounds 2. Clinical uses 1) Nonspecific treatment of peptic ulcers, dyspepsia and acute diarrhea. 2) Used in multidrug regimens for the eradication of H pylori infection. 3. Adverse effects Causes blackening of the stool Bismuth toxicity resulting in encephalopathy (脑病, ataxia, headaches, confusion, seizures)- used for short period and contraindicated in patients with renal insufficiency. Other mucosal protective drugs Teprenone (替普瑞酮) Marzulene-S (麦滋林-S) Smectite (蒙脱石,思密达) Antimicrobial drugs (for Helicobacter pylori) 1. Anti-ulcer drugs H+-K+-ATPase inhibitors; bismuch; sulralfate Weaker, combined with antimicrobial drugs 2. Antibiotics metronidazole (甲硝唑); amoxicillin (阿莫西林); tetracycline (四环素); gentamicin (庆大霉素); clarithromycin (克拉霉素) The best treatment regimen consists of a 10-14 day regimen of "triple therapy": Program 1 1) A proton pump inhibitor twice daily, 2) Clarithromycin 500 mg twice daily, 3) Amoxicillin 1 g twice daily. For patients who are allergic to penicillin, metronidazole 500 mg twice daily should be substituted for amoxicillin. Program 2 1) Bismuth subsalicylate (2 tablets; 262 mg each), 2) Tetracycline (500 mg), 3) Metronidazole (250 mg), each taken four times daily for 14 days. For patients with resistant infections, "quadruple therapy” 1) A proton pump inhibitor twice daily 2) Bismuth subsalicylate (2 tablets; 262 mg each), 3) Tetracycline (500 mg), 4) Metronidazole (250 mg), each taken four times daily for 14 days. Gastrointestinal drugs 1. Drugs used for acid-peptic disorders 2. Modulators of gastrointestinal functions Abnormalities of gastrointestinal functions Nausea and vomiting Diarrhea Constipation Modulators of gastrointestinal functions 1. Digestants (助消化药) 2. Antiemetics (止吐药) 3. Prokinetic drugs (胃肠动力药) 4. Anti-diarrheals (止泻药) 5. Laxatives (泻药) Modulators of gastrointestinal functions Digestants(助消化药) § Pepsin(胃蛋白酶) § Pancreatin (胰酶): § Lactasin(乳酶生):乳酸杆菌制剂 § Carnitine(肉碱,卡尼丁) Modulators of gastrointestinal functions Antiemetic drugs H1 receptor antagonists: diphenhydramine 苯海拉明; dimenhydrinate 茶苯海明; meclozine 美克洛嗪 Muscarinic receptor antagonists: scopolamine 东莨 菪碱 D2 receptor antagonists: chlorpromazine 氯丙嗪 5-HT3 receptor antagonists:ondansetron 昂丹司琼; grasetron 格拉司琼; tropisetron 托烷司琼 Prokinetic drugs (Central or peripheral) NANC neuron (-) Metoclopramide 甲氧氯普胺 Postganglionic primary motor neuron GI tract smooth muscle cells Metoclopramide 甲氧氯普胺 Mechanism of action 1) A 5-HT4 receptor agonist and 5-HT3 receptor antagonist, enhances coordinated transmission in cholinergic nerve plexus 2) A D2 receptor antagonist Clinical uses 1) Used for treatment of diabetic gastroparesis (胃瘫) 2) Used for the prevention of nausea and vomiting associated with cancer chemotherapy or occurring post-operatively. Metoclopramide 甲氧氯普胺 Adverse effects 1) Fatigue, dizziness, faintness 2) Various extrapyramidal syndromes锥体外系综合征: Parkinsonism帕金森症 (reversible) tardive dyskinesia迟发性运动障碍 (irreversible) 3) Increased serum prolactin催乳素 levels (chronic uses) Domperidone 多潘立酮 Mechanism of action A peripheral dopamine D2 antagonist Adverse effects Few side effects since it can not cross the BBB Increased serum prolactin levels ( 6% of patients) Rare cases of prolongation of QT interval. Modulators of gastrointestinal functions Antidiarrheals止泻药 Causes of diarrhea: 1) An increase in the active secretion, or an inhibition of absorption 2) Abnormally high motility Antidiarrheals 1. Antimotility drugs (胃肠动力抑制药) 2. Astringents (收敛药) 3. Absorbants (吸附药) Antimotility drugs Mechanisms: Agonists for receptors in GI tract (1) Opium preparation (2) Diphenoxylate 地芬诺酯:dose not cross the blood-brain-barrier as easily as most opioids and is relatively selective for peripheral opioid receptors. (3) Loperamine 洛哌丁胺:more potent, rapid and longer than diphenoxylate, without analgesic effects. Astringents收敛药 Mechanism: astriction (1) Tannalbin 鞣酸蛋白 (2) Bismuch subsalicylate; bismuch subcarbonate (铋制剂) Absorbents吸附药 (1) Medical charchol 药用炭(活性炭) (2) Agysical 矽炭银(活性炭+白陶土) Modulators of gastrointestinal functions Laxatives泻药 Constipation: An decrease in the active secretion, or an enhancement of absorption Treatment 1) Increase the intake of fluids and dietary fiber 2) Physical intervention, regular exercise 3) Laxatives Laxatives泻药 1. Laxatives that increase secretion 2. Laxatives that work osmotically 3. Laxatives that decrease absorption Laxatives 1. Laxatives that increase secretion Phenolphthalein 酚酞 ( No longer used because of concerns about carcigenicity) Bisacodyl 必沙可啶 (It is active after deacetylation, inhibits Na+/K+-ATPase and increases the synthesis and release of PGE2) Laxatives 1. Laxatives that increase secretion Anthraquinones 蒽醌类(中药成分) Glycoside conjugates free anthraquinone active anthral form Inhibiting colonic mucosal Na+/K+-ATPase Rhamnus (鼠李) Rhubarb (大黄) Senna (番泻叶) Laxatives 2. Laxatives that work osmotically 1) Salt laxatives: magnesium sulfate 硫 酸镁; sodium sulfate 硫酸钠; These agents contain ions that are only slowly absorbed from the intestine. These ions retain fluid in the bowel lumen and cause a large volume of fluid to enter the colon. Laxatives 2. Laxatives that work osmotically 2) Lactulose 乳果糖; In the small bowel, it is resistant to hydrolysis and has an osmotic effect. In the large intestine, lactulose is acted upon by the endogenous flora with the production of lactic acid乳酸, Lactic acid also has an osmotic effect. It is used to reduce ammonia blood levels in the prevention and treatment of hepatic encephalopathy Laxatives 3. Laxatives that decrease absorption Liquid petrolatum液体石蜡 ( Lubricate the fecal mass, prevent excessive dehydration of the material , and may inhibit water reabsorption by coating the gut wall) Modulators of gastrointestinal functions Choleretic(利胆药) Ursodeoxycholic acid (熊去氧胆酸) Dehydrocholic acid (去氢胆酸) Chenodeoxycholic acid (鹅去氧胆酸) Magnesium sulfate (硫酸镁)